HomeComparePARNF vs MRK

PARNF vs MRK: Dividend Comparison 2026

PARNF yields 2500.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PARNF wins by $80609755877.31M in total portfolio value
10 years
PARNF
PARNF
● Live price
2500.00%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80609755877.37M
Annual income
$74,729,580,081,858,750.00
Full PARNF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PARNF vs MRK

📍 PARNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPARNFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PARNF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PARNF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PARNF
Annual income on $10K today (after 15% tax)
$212,500.00/yr
After 10yr DRIP, annual income (after tax)
$63,520,143,069,579,940.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PARNF beats the other by $63,520,143,069,571,610.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PARNF + MRK for your $10,000?

PARNF: 50%MRK: 50%
100% MRK50/50100% PARNF
Portfolio after 10yr
$40304877938.71M
Annual income
$37,364,790,040,934,270.00/yr
Blended yield
92.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PARNF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PARNF buys
0
MRK buys
0
No recent congressional trades found for PARNF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPARNFMRK
Forward yield2500.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$80609755877.37M$56.8K
Annual income after 10y$74,729,580,081,858,750.00$9,798.13
Total dividends collected$80198875900.38M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PARNF vs MRK ($10,000, DRIP)

YearPARNF PortfolioPARNF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$260,700$250,000.00$11,206$366.19+$249.5KPARNF
2$6,370,070$6,091,121.50$12,650$502.35+$6.36MPARNF
3$145,912,632$139,096,656.81$14,407$694.19+$145.90MPARNF
4$3,133,830,814$2,977,704,297.75$16,585$967.82+$3133.81MPARNF
5$63,122,812,060$59,769,613,088.96$19,342$1,363.89+$63122.79MPARNF
6$1,192,683,724,131$1,125,142,315,226.76$22,913$1,947.19+$1192683.70MPARNF
7$21,144,559,711,004$19,868,388,126,183.19$27,662$2,823.89+$21144559.68MPARNF
8$351,818,906,448,043$329,194,227,557,269.44$34,159$4,173.35+$351818906.41MPARNF
9$5,495,491,397,671,320$5,119,045,167,771,913.00$43,337$6,308.80+$5495491397.63MPARNF
10$80,609,755,877,367,070$74,729,580,081,858,750.00$56,776$9,798.13+$80609755877.31MPARNF

PARNF vs MRK: Complete Analysis 2026

PARNFStock

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Full PARNF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PARNF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PARNF vs SCHDPARNF vs JEPIPARNF vs OPARNF vs KOPARNF vs MAINPARNF vs JNJPARNF vs ABBVPARNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.